Mkts

Ocular Therapeutix, Inc.

NASDAQ: OCUL
$6.59+0.17 (+2.57%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
6.526.75
52-week range
6.0016.44
Today
Open6.53
Previous close6.59
Volume—
Valuation
Market cap1.45B
P/E ratio—
EPS (TTM)-1.41
Income & risk
Dividend / yield—
Beta1.24
Avg volume2.79M
Discussion

OCUL News

Stories mentioning OCUL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue10,78513,25014,54413,45910,69817,08315,42516,441
Cost of Goods Sold1,3291,5941,7741,9441,2621,2301,5611,509
Gross Profit9,45611,65612,77011,5159,43615,85313,86414,932
Operating Expenses
Research & Development66,21350,80052,35851,08142,85740,98937,05428,857
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(93,340)(69,761)(68,698)(67,641)(63,917)(50,576)(45,998)(43,590)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(88,612)(64,654)(69,418)(67,814)(64,053)(48,388)(36,493)(43,777)
Earnings Per Share (Basic)(0.40)(0.35)(0.38)(0.39)(0.38)(0.31)(0.22)(0.26)
Earnings Per Share (Diluted)(0.40)(0.35)(0.38)(0.39)(0.38)(0.31)(0.22)(0.26)
Weighted Average Shares Outstanding (Basic)224,099187,241183,920172,595169,397158,265166,993165,825
Weighted Average Shares Outstanding (Diluted)224,099187,241183,920172,595169,397158,265166,993165,825

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OCUL

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a stock listed on the Nasdaq Stock Market under the ticker symbol OCUL. It last traded at $6.59 (Nov 6, 2026, 4:00 PM ET), up 2.6% on the day. That gives Ocular Therapeutix a market capitalisation of $1.4B.

Over the past 52 weeks OCUL has traded between $6.00 and $16.44.

Revenue for the quarter ended Mar 31, 2026 was $10.8M; a net loss of $88.6M. Revenue was up 0.8% from $10.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$10.8M-$88.6M-821.6%
Dec 31, 2025$13.3M-$64.7M-488.0%
Sep 30, 2025$14.5M-$69.4M-477.3%
Jun 30, 2025$13.5M-$67.8M-503.9%

From Ocular Therapeutix’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…